IL-12 and IL-23 Therapeutic Targets Reviewed

Slideshow

Slideshow Summary: Researchers have clarified the contribution of IL-12 and IL-23 in immune regulation.

References:

Teng MW, et al. 

“IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases.”

 

Nature Medicine 

2015 Jul;21(7):719-29. doi: 10.1038/nm.3895. Epub 2015 Jun 29

Recent Videos
Alvin Wells, MD, PhD
Upcoming Research in PsA, AxSpa, with Philip Mease, MD
Philip Mease, MD, Clinical Professor, University of Washington School of Medicine and Director, Rheumatology Research, Swedish Medical Center
Signs and Symptoms of Connective Tissue Disease
Connective Tissue Disease Brings Dermatology & Rheumatology Together
© 2024 MJH Life Sciences

All rights reserved.